Source link : https://newshealth.biz/health-news/bcma-car-t-yields-100-response-rate-in-small-al-amyloidosis-trial/
(MedPage Today) — As CAR T-cell therapy has become a transformative option in multiple myeloma, a first-of-its-kind trial now extends that potential to relapsed/refractory light chain (AL) amyloidosis. At the recent American Society of Clinical… Source link : https://www.medpagetoday.com/meetingcoverage/ascovideopearlsmm/116164 Author : Publish date : 2025-06-20 15:06:00 Copyright for syndicated content belongs to the linked Source.
The post BCMA CAR-T Yields 100% Response Rate in Small AL Amyloidosis Trial first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-20 15:06:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8